Irina Bonzheim

19PUBLICATIONS
80CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersMedical mycologyCancer geneticsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 09, 2026
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker.

Elena Sophia Lindner, Jakob Admard, German Demidov

|Sep 04, 2025
Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis.

Dominik Nann, Tim-Colin Schade, Mathis Overkamp

|Oct 09, 2024
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition.

Christopher Schroeder, Sergios Gatidis, Olga Kelemen

|Aug 27, 2024
Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations.

Hannes Armbruster, Tilman Schotte, Isabell Götting

|Aug 10, 2024
An Automated Real-Time PCR Assay versus Next-Generation Sequencing in the Detection of BRAF V600 Mutations in Melanoma Tissue Samples.

Daniela Lenders, Irina Bonzheim, Matthias Hahn

Pageof 4